Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies.

[1]  Sara M. Willems,et al.  Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. , 2016, JAMA.

[2]  J. DiNicolantonio,et al.  The importance of a balanced ω-6 to ω-3 ratio in the prevention and management of obesity , 2016, Open Heart.

[3]  A. McAinch,et al.  Linoleic acid and the pathogenesis of obesity. , 2016, Prostaglandins & other lipid mediators.

[4]  D. Mozaffarian,et al.  Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials , 2016, PLoS medicine.

[5]  D. van der A,et al.  Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study , 2016, PLoS medicine.

[6]  D. Mozaffarian,et al.  ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. , 2016, JAMA internal medicine.

[7]  J. Pais de Barros,et al.  Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production* , 2016, The Journal of Biological Chemistry.

[8]  John M. Davis,et al.  Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73) , 2016, British Medical Journal.

[9]  M. Jastroch,et al.  Palmitate-induced impairment of glucose-stimulated insulin secretion precedes mitochondrial dysfunction in mouse pancreatic islets. , 2016, The Biochemical journal.

[10]  M. Schulze,et al.  Erythrocyte membrane fatty acid fluidity and risk of type 2 diabetes in the EPIC-Potsdam study , 2014, Diabetologia.

[11]  L. Lauritzen,et al.  Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review , 2014, Food & nutrition research.

[12]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[13]  W. Guan,et al.  Genome-Wide Association Study of Plasma N6 Polyunsaturated Fatty Acids Within the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium , 2014, Circulation. Cardiovascular genetics.

[14]  Simon G Thompson,et al.  Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. , 2014, Annals of internal medicine.

[15]  D. Ma,et al.  The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease. , 2014, Food & function.

[16]  K. Fritsche,et al.  Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. , 2012, Journal of the Academy of Nutrition and Dietetics.

[17]  M. Uusitupa,et al.  Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. , 2012, The American journal of clinical nutrition.

[18]  J. Whelan,et al.  Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review , 2011, Nutrition & metabolism.

[19]  S. Sharp,et al.  Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. , 2010, The American journal of clinical nutrition.

[20]  Dan Jackson,et al.  Extending DerSimonian and Laird's methodology to perform multivariate random effects meta‐analyses , 2009, Statistics in medicine.

[21]  D. Mozaffarian,et al.  Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention , 2009, Circulation.

[22]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[23]  D. English,et al.  Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.

[24]  J. McKenzie,et al.  Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. , 2006, The Journal of nutrition.

[25]  Sander Greenland,et al.  Generalized Least Squares for Trend Estimation of Summarized Dose–response Data , 2006 .

[26]  R. Reynoso,et al.  High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1 , 2003, Molecular and Cellular Biochemistry.

[27]  Lenore Arab,et al.  Biomarkers of fat and fatty acid intake. , 2003, The Journal of nutrition.

[28]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[29]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .